⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

BEAM

Beam Therapeutics Inc.

Healthcare · Biotechnology

25.175USD

-1.6550 (-6.17%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 25.18
P/E—
Dvd Ind Yld—
P/B2.44
P/S16.7
Curr EV/T12M EBITDA-5.0
Mkt Cap (USD)2.6B
Curr EV (USD)1.8B
2)

Per Share Data

EPS T12M-0.72
DPS—
Bk Val Per Sh10.69
Rev/Sh1.50
Cash/Sh11.54
Curr Shares Out103.3M
FCF/Sh-3.57
3)

Cash Flow Analysis

P/CF-7.2
Curr P/FCF-7.0
CF/NI4.2
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-230.3%
Eff Interest Rate—
4)

Growth Potential

Dil EPS 1Y Gr82.3%
Cap 1Y Gr68.8%
BPS 1Y Gr40.5%
R&D To Sales261.9%
Retention Rate100.0%
Rev 1Y Gr120.0%
FCF 1Y Gr-1.1%
Assets 1Y Gr34.2%
5)

Profitability

EBITDA-0.4B
EBIT-0.4B
Operating Margin-242.3%
Pretax Margin-39.1%
Net Margin-54.7%
ROA-6.2%
ROE-8.1%
ROC-28.8%
Asset Turnover0.11
6)

Structure

Current Ratio14.57
Quick Ratio14.25
Debt/Assets17.8%
Debt/Com Eq23.2%
Net Debt/EBITDA-0.08
Tot Debt/Capital18.8%
Gross Margin-161.9%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.